Drug name - Yonsa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9889144 SUN PHARM Abiraterone acetate formulation and methods of use Mar, 2034

(11 years from now)

US10292990 SUN PHARM Abiraterone steroid formulation May, 2034

(11 years from now)

Drugs and Companies using ABIRATERONE ACETATE ingredient

Treatment: Use in combination with methylprednisolone for the treatment of patients with prostate cancer

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
125MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.